Omrix Biopharmaceuticals, Inc. (OMRI) has 22 open-market insider trades by 12 insiders since 2006. The most active filer is Bernard Horowitz, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert Taub | CEO | — | 3 | $24.6M | 2008-11-23 |
| Michael Burshtine | — | — | 2 | $3.9M | 2008-01-04 |
| Philippe Romagnoli | Dir | — | 3 | $2.4M | 2008-09-04 |
| Fredric D. Price | Dir | — | 1 | $1.7M | 2007-06-04 |
| Nissim Mashiach | Pres | — | 3 | $1.4M | 2008-10-10 |
| Luke Evnin | — | — | 1 | $1.0M | 2006-11-02 |
| Ansbert Gadicke | — | — | 1 | $582K | 2006-11-02 |
| Bernard Horowitz | Dir | — | 4 | $108K | 2008-09-04 |
| Peter Steven St | Dir | — | 1 | $81K | 2008-09-04 |
| V. Marc Droppert | PresVP | — | 1 | $50K | 2008-03-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Nissim Mashiach | President | Buy | $29K | 2008-03-31 |
| Philippe Romagnoli | Director | Buy | $106K | 2008-03-26 |
| Kevin Rakin | Director | Buy | $27K | 2008-03-26 |
| Robert Taub | CEO | Buy | $979K | 2008-03-19 |
| Philippe Romagnoli | Director | Buy | $270K | 2008-03-19 |
| V. Marc Droppert | President & VP | Buy | $50K | 2008-03-18 |
Companies that share insiders with OMRI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Michael Burshtine | — | Sell | $1.1M | 2008-01-04 |
| Michael Burshtine | — | Sell | $2.8M | 2008-01-02 |
| Nissim Mashiach | Senior VP & Operations | Sell | $345K | 2007-12-11 |
| General Counsel | Sell | $338K | 2007-11-08 |
| Peter Steven St | Director | Sell | $81K | 2007-08-13 |
| Bernard Horowitz | Director | Sell | $69K | 2007-06-05 |
| Fredric D. Price | Director | Sell | $1.7M | 2007-06-04 |
| Robert Taub | CEO & Pres. | Sell | $3.1M | 2007-01-17 |
| Philippe Romagnoli | President & VP +1 | Sell | $2.0M | 2006-12-20 |